Related Experiment Video
Updated: Jun 19, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma
Yasuhiro Ito1, Kazumori Arai, Ryushi Nozawa
1Department of Surgery, Kuma Hospital, 8-2-35, Shimoyamate-dori, Chuo-ku, Kobe 650-0011, Japan. ito01@kuma-h.or.jp
Background:
S100A8 plays a role in various functions of myeloid cells by forming a heterocomplex with S100A9. S100A8 and S100A9 are also known to be overexpressed in certain species of carcinomas.
Materials And Methods:
In this study, the protein expression of S100A8 as well as that of S100A9 was investigated in thyroid tumors.
Results:
All of the undifferentiated carcinomas were immunopositive for S100A8 and S100A9 and overlap between staining patterns of both proteins was observed. In poorly differentiated carcinomas, all the cases were negative for S100A8, while slight immunopositivity of S100A9 was seen in 2 cases. Papillary carcinoma, follicular carcinoma, follicular adenoma and medullary carcinoma and normal follicules were negative for both proteins.
Conclusion:
S100A8 plays an important role in dedifferentiation of thyroid carcinoma possibly by forming a complex with S100A9.